<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of inserm-00579959</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-21T04:40:06+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension.</title>
            <title xml:lang="en" type="sub">Autocrine Loop of EC-Derived FGF2 in IPAH</title>
            <author role="aut">
              <persName>
                <forename type="first">Ly</forename>
                <surname>Tu</surname>
              </persName>
              <email type="md5">968f6c2c0dcf8d1ea10fbc1a12e158f5</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="numeric">761927</idno>
              <idno type="halauthorid" notation="string">427942-761927</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2336-5099</idno>
              <idno type="IDREF">https://www.idref.fr/162030649</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Laurence</forename>
                <surname>Dewachter</surname>
              </persName>
              <idno type="halauthorid">427941-0</idno>
              <affiliation ref="#struct-303388"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Benoit</forename>
                <surname>Gore</surname>
              </persName>
              <idno type="halauthorid">546810-0</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Elie</forename>
                <surname>Fadel</surname>
              </persName>
              <email type="md5">3b62e6d69260846fd3ca242eaada0b2f</email>
              <email type="domain">ccml.com</email>
              <idno type="idhal" notation="numeric">1252794</idno>
              <idno type="halauthorid" notation="string">341703-1252794</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-9290-4589</idno>
              <idno type="IDREF">https://www.idref.fr/109055632</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Philippe</forename>
                <surname>Dartevelle</surname>
              </persName>
              <idno type="halauthorid">197720-0</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Gérald</forename>
                <surname>Simonneau</surname>
              </persName>
              <idno type="halauthorid">427943-0</idno>
              <affiliation ref="#struct-120468"/>
              <affiliation ref="#struct-116337"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marc</forename>
                <surname>Humbert</surname>
              </persName>
              <email type="md5">c96ebb0e3ab5bf9eeaf5a83544944f85</email>
              <email type="domain">abc.aphp.fr</email>
              <idno type="idhal" notation="numeric">1113540</idno>
              <idno type="halauthorid" notation="string">158428-1113540</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-0703-2892</idno>
              <idno type="IDREF">https://www.idref.fr/071559426</idno>
              <affiliation ref="#struct-120468"/>
              <affiliation ref="#struct-116337"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Saadia</forename>
                <surname>Eddahibi</surname>
              </persName>
              <idno type="halauthorid">193244-0</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <author role="crp">
              <persName>
                <forename type="first">Christophe</forename>
                <surname>Guignabert</surname>
              </persName>
              <email type="md5">19dbdb5965ab68c38865a122a5dcf169</email>
              <email type="domain">inserm.fr</email>
              <idno type="idhal" notation="string">christophe-guignabert</idno>
              <idno type="idhal" notation="numeric">184750</idno>
              <idno type="halauthorid" notation="string">10960-184750</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/G-3873-2013</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8545-4452</idno>
              <idno type="IDREF">https://www.idref.fr/095316213</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/G-3873-2013</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=11rsPwQAAAAJ</idno>
              <idno type="VIAF">https://viaf.org/viaf/214257028</idno>
              <idno type="ISNI">http://isni.org/isni/000000013925142X</idno>
              <affiliation ref="#struct-120468"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Christophe</forename>
                <surname>Guignabert</surname>
              </persName>
              <email type="md5">19dbdb5965ab68c38865a122a5dcf169</email>
              <email type="domain">inserm.fr</email>
            </editor>
            <funder>This research was supported by grants from the French National Institute for Health and Medical Research (INSERM), the Legs Poix (Chancellerie des Universités de Paris), and the French National Agency for Research ("Agence Nationale de la Recherche" - ANR), Paris, France; grant no. P007948 GENOPATH-ATOL.</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2011-03-25 15:18:43</date>
              <date type="whenModified">2026-04-27 16:13:23</date>
              <date type="whenReleased">2011-03-25 16:11:35</date>
              <date type="whenProduced">2011-08</date>
              <date type="whenEndEmbargoed">9999-12-31</date>
              <ref type="file" target="https://inserm.hal.science/inserm-00579959v1/document">
                <date notBefore="9999-12-31"/>
              </ref>
              <ref type="file" subtype="author" n="1" target="https://inserm.hal.science/inserm-00579959v1/file/AJRCMB_Tu_et_al_revised_MS_and_Figures.pdf" id="file-579959-725456">
                <date notBefore="9999-12-31"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834126"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="132762">
                <persName>
                  <forename>Christophe</forename>
                  <surname>Guignabert</surname>
                </persName>
                <email type="md5">19dbdb5965ab68c38865a122a5dcf169</email>
                <email type="domain">inserm.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">inserm-00579959</idno>
            <idno type="halUri">https://inserm.hal.science/inserm-00579959</idno>
            <idno type="halBibtex">tu:inserm-00579959</idno>
            <idno type="halRefHtml">&lt;i&gt;American Journal of Respiratory Cell and Molecular Biology&lt;/i&gt;, 2011, 45 (2), pp.311-22. &lt;a target="_blank" href="https://dx.doi.org/10.1165/rcmb.2010-0317OC"&gt;&amp;#x27E8;10.1165/rcmb.2010-0317OC&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">American Journal of Respiratory Cell and Molecular Biology, 2011, 45 (2), pp.311-22. &amp;#x27E8;10.1165/rcmb.2010-0317OC&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-579959-725456"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="UNIV-PSUD">Université Paris Sud - Paris XI</idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="UNIV-PARIS-SACLAY">Université Paris-Saclay</idno>
            <idno type="stamp" n="UNIV-PSUD-SACLAY" corresp="UNIV-PARIS-SACLAY">Université Paris Sud pour Paris Saclay</idno>
            <idno type="stamp" n="GS-HEALTH-DRUG-SCIENCES">Graduate School Health and Drug Sciences</idno>
            <idno type="stamp" n="HPPIT">Hypertension pulmonaire : physiopathologie et innovation thérapeutique</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension.</title>
                <title xml:lang="en" type="sub">Autocrine Loop of EC-Derived FGF2 in IPAH</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Ly</forename>
                    <surname>Tu</surname>
                  </persName>
                  <email type="md5">968f6c2c0dcf8d1ea10fbc1a12e158f5</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="numeric">761927</idno>
                  <idno type="halauthorid" notation="string">427942-761927</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2336-5099</idno>
                  <idno type="IDREF">https://www.idref.fr/162030649</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Laurence</forename>
                    <surname>Dewachter</surname>
                  </persName>
                  <idno type="halauthorid">427941-0</idno>
                  <affiliation ref="#struct-303388"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Benoit</forename>
                    <surname>Gore</surname>
                  </persName>
                  <idno type="halauthorid">546810-0</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Elie</forename>
                    <surname>Fadel</surname>
                  </persName>
                  <email type="md5">3b62e6d69260846fd3ca242eaada0b2f</email>
                  <email type="domain">ccml.com</email>
                  <idno type="idhal" notation="numeric">1252794</idno>
                  <idno type="halauthorid" notation="string">341703-1252794</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-9290-4589</idno>
                  <idno type="IDREF">https://www.idref.fr/109055632</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Philippe</forename>
                    <surname>Dartevelle</surname>
                  </persName>
                  <idno type="halauthorid">197720-0</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Gérald</forename>
                    <surname>Simonneau</surname>
                  </persName>
                  <idno type="halauthorid">427943-0</idno>
                  <affiliation ref="#struct-120468"/>
                  <affiliation ref="#struct-116337"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marc</forename>
                    <surname>Humbert</surname>
                  </persName>
                  <email type="md5">c96ebb0e3ab5bf9eeaf5a83544944f85</email>
                  <email type="domain">abc.aphp.fr</email>
                  <idno type="idhal" notation="numeric">1113540</idno>
                  <idno type="halauthorid" notation="string">158428-1113540</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-0703-2892</idno>
                  <idno type="IDREF">https://www.idref.fr/071559426</idno>
                  <affiliation ref="#struct-120468"/>
                  <affiliation ref="#struct-116337"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Saadia</forename>
                    <surname>Eddahibi</surname>
                  </persName>
                  <idno type="halauthorid">193244-0</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
                <author role="crp">
                  <persName>
                    <forename type="first">Christophe</forename>
                    <surname>Guignabert</surname>
                  </persName>
                  <email type="md5">19dbdb5965ab68c38865a122a5dcf169</email>
                  <email type="domain">inserm.fr</email>
                  <idno type="idhal" notation="string">christophe-guignabert</idno>
                  <idno type="idhal" notation="numeric">184750</idno>
                  <idno type="halauthorid" notation="string">10960-184750</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/G-3873-2013</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8545-4452</idno>
                  <idno type="IDREF">https://www.idref.fr/095316213</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/G-3873-2013</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=11rsPwQAAAAJ</idno>
                  <idno type="VIAF">https://viaf.org/viaf/214257028</idno>
                  <idno type="ISNI">http://isni.org/isni/000000013925142X</idno>
                  <affiliation ref="#struct-120468"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">18472</idno>
                <idno type="issn">1044-1549</idno>
                <idno type="eissn">1535-4989</idno>
                <title level="j">American Journal of Respiratory Cell and Molecular Biology</title>
                <imprint>
                  <publisher>American Thoracic Society</publisher>
                  <biblScope unit="volume">45</biblScope>
                  <biblScope unit="issue">2</biblScope>
                  <biblScope unit="pp">311-22</biblScope>
                  <date type="datePub">2011-08</date>
                  <date type="dateEpub">2010-10-29</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1165/rcmb.2010-0317OC</idno>
              <idno type="pubmed">21037114</idno>
              <idno type="pubmedcentral">PMC4834126</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">endothelium</term>
                <term xml:lang="en">growth factors</term>
                <term xml:lang="en">survival</term>
                <term xml:lang="en">proliferation</term>
                <term xml:lang="en">FGF-receptors</term>
              </keywords>
              <classCode scheme="mesh">Adolescent</classCode>
              <classCode scheme="mesh">Adult</classCode>
              <classCode scheme="mesh">Fibroblast Growth Factor 2</classCode>
              <classCode scheme="mesh">Humans</classCode>
              <classCode scheme="mesh">Hypertension, Pulmonary</classCode>
              <classCode scheme="mesh">Male</classCode>
              <classCode scheme="mesh">Middle Aged</classCode>
              <classCode scheme="mesh">Phenotype</classCode>
              <classCode scheme="mesh">Phosphorylation</classCode>
              <classCode scheme="mesh">Proto-Oncogene Proteins c-bcl-2</classCode>
              <classCode scheme="mesh">RNA, Messenger</classCode>
              <classCode scheme="mesh">RNA, Small Interfering</classCode>
              <classCode scheme="mesh">Apoptosis</classCode>
              <classCode scheme="mesh">Reverse Transcriptase Polymerase Chain Reaction</classCode>
              <classCode scheme="mesh">Young Adult</classCode>
              <classCode scheme="mesh">bcl-X Protein</classCode>
              <classCode scheme="mesh">Autocrine Communication</classCode>
              <classCode scheme="mesh">Blotting, Western</classCode>
              <classCode scheme="mesh">Case-Control Studies</classCode>
              <classCode scheme="mesh">Cell Proliferation</classCode>
              <classCode scheme="mesh">Cells, Cultured</classCode>
              <classCode scheme="mesh">Endothelium, Vascular</classCode>
              <classCode scheme="mesh">Female</classCode>
              <classCode scheme="halDomain" n="sdv.bc">Life Sciences [q-bio]/Cellular Biology</classCode>
              <classCode scheme="halDomain" n="sdv.bbm">Life Sciences [q-bio]/Biochemistry, Molecular Biology</classCode>
              <classCode scheme="halDomain" n="sdv.mhep.phy">Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Pulmonary vascular remodeling is key to the pathogenesis of idiopathic pulmonary arterial hypertension (IPAH). We recently reported that fibroblast growth factor (FGF)2 is markedly overproduced by pulmonary endothelial cells (P-ECs) in IPAH and contributes significantly to smooth muscle hyperplasia and disease progression. Excessive FGF2 expression in malignancy exerts pathologic effects on tumor cells by paracrine and autocrine mechanisms.We hypothesized that FGF2 overproduction contributes in an autocrine manner to the abnormal phenotype of P-ECs, characteristic of IPAH. In distal pulmonary arteries (PAs) of patients with IPAH, we found increased numbers of proliferating ECs and decreased numbers of apoptotic ECs, accompanied with stronger immunoreactivity for the antiapoptotic molecules, B-cell lymphoma (BCL)2, and BCL extra long (BCL-xL) compared with PAs from control patients. These in situ observations were replicated in vitro, with cultured P-ECs from patients IPAH exhibiting increased proliferation and diminished sensitivity to apoptotic induction with marked increases in the antiapoptotic factors BCL2 and BCL-xL and levels of phosphorylated extracellular signal-regulated (ERK)1/2 compared with control P-ECs. IPAH P-ECs also exhibited increased FGF2 expression and an accentuated proliferative and survival response to conditioned P-EC media or exogenous FGF2 treatment. Decreasing FGF2 signaling by RNA interference normalized sensitivity to apoptosis and proliferative potential in the IPAH P-ECs. Our findings suggest that excessive autocrine release of endothelial-derived FGF2 in IPAH contributes to the acquisition and maintenance of an abnormal EC phenotype, enhancing proliferation through constitutive activation of ERK1/2 and decreasing apoptosis by increasing BCL2 and BCL-xL.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-120468" status="OLD">
          <orgName>Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique</orgName>
          <orgName type="acronym">HPPIT</orgName>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>133 avenue de la Résistance, 92350 Le Plessis-Robinson</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.htapfrance.com/je-m-informe/voies_de_recherche.asp?rubrique=2</ref>
          </desc>
          <listRelation>
            <relation active="#struct-92966" type="direct"/>
            <relation active="#struct-217059" type="direct"/>
            <relation name="U999" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-303388" status="VALID">
          <idno type="IdRef">034905812</idno>
          <idno type="ISNI">0000 0001 2348 0746</idno>
          <idno type="ROR">https://ror.org/01r9htc13</idno>
          <orgName>Université libre de Bruxelles = Free University of Brussels</orgName>
          <orgName type="acronym">ULB</orgName>
          <date type="start">1970-01-01</date>
          <desc>
            <address>
              <addrLine>Avenue Franklin Roosevelt 50 - 1050 Bruxelles</addrLine>
              <country key="BE"/>
            </address>
            <ref type="url">https://www.ulb.be/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-116337" status="OLD">
          <orgName>Hôpital Antoine Béclère</orgName>
          <desc>
            <address>
              <addrLine>157 rue de la Porte de Trivaux, F-92141 Clamart Cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-92966" type="direct"/>
            <relation active="#struct-300068" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-92966" status="OLD">
          <idno type="ROR">https://ror.org/028rypz17</idno>
          <orgName>Université Paris-Sud - Paris 11</orgName>
          <orgName type="acronym">UP11</orgName>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>Bâtiment 300 - 91405 Orsay cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-psud.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-217059" status="OLD">
          <idno type="ROR">https://ror.org/029gxzx35</idno>
          <orgName>Centre Chirurgical Marie Lannelongue</orgName>
          <orgName type="acronym">CCML</orgName>
          <desc>
            <address>
              <addrLine>133 avenue de la Résistance - 92350 Le Plessis Robinson Plessis Robinson</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ccml.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>